%0 Journal Article %T Outcome and Prospective Factor Analysis of High-dose Therapy Combined with Autologous Peripheral Blood Stem Cell Transplantation in Patients with Peripheral T-cell Lymphomas %A Chen Zhang %A Jun Zhu %A Lijuan Deng %A Lingyan Ping %A Meifeng Tu %A Meng Wu %A Ningjing Lin %A Weiping Liu %A Wen Zheng %A Xiaopei Wang %A Yan Xie %A Yuqin Song %A Zhitao Ying %J International Journal of Medical Sciences %D 2018 %R 10.7150/ijms.23067 %X Background: For peripheral T-cell lymphomas (PTCLs) patients, high-dose therapy combined with autologous peripheral blood stem cell transplantation (HDT/ASCT) has been an alternative treatment option, due to the lack of efficacy from conventional chemotherapy. While not all PTCLs could have benefit in survival from HDT/ASCT. The aim of this study was to evaluate the value of high-dose therapy combined with autologous peripheral blood stem cell transplantation (HDT/ASCT) in Chinese patients with Peripheral T-cell Lymphomas (PTCLs), in order to determine the cohort most suitable to receive HDT/ASCT. %K Peripheral T-cell lymphomas %K High dose chemotherapy %K Autologous peripheral blood stem cell transplantation %K Retrospective study %U http://www.medsci.org/v15p0867.htm